In spite of this buzz about involvement of COX in AD, clinical studies carried out with NSAIDs and selective COX-2 inhibitors did not show any significant effects in treatment of AD (Hoozemans et al., 2008). The gene discussed is PTGS2; the disease is Alzheimer disease.